-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary24/falls-prevention-in-older-adults-counseling-and-preventive-medication-2012
December 15, 2010 - are more successful in preventing falls 13 , interventions were categorized during the abstraction phase
-
www.ahrq.gov/research/shuttered/acfselection/chapter4.html
July 01, 2018 - This template should be altered during the planning phase to reflect local variables and the planned
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/alcohol-pharma-final-protocol.pdf
January 01, 2023 - review the full text of all titles marked for possible
inclusion during the title/abstract review phase
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/dementia-older-adults-screening-2003
June 03, 2003 - The two Task Force liaisons participated in every phase of the review, including conference calls to
-
digital.ahrq.gov/sites/default/files/docs/page/09-0069-EF_1.pdf
June 01, 2009 - should be done as one of the first steps in the
development process, usually in the needs assessment phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
June 15, 2016 - arthroscopic administration of mesenchymal stem-cells or
chondrocytes or tissue
§ Exclusions:
• Phase
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs023808-grannis-final-report-2023.pdf
January 01, 2023 - Optimal two-phase sampling design for comparing accuracies of two binary
classification rules.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary20/depression-in-adults-screening-2009
December 15, 2009 - Cipriani et al, 2007 95
Review of reviews of acute-phase treatment with antidepressants.
-
hcup-us.ahrq.gov/toolssoftware/ccsr/DXCCSR-User-Guide-v2025-1.pdf
November 01, 2024 - sequela, where applicable.13 A sequela is the residual effect (condition produced) after
the acute phase … designated by a seventh character of S, is the residual effect (condition produced)
after the acute phase
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-year3-final-report-2019.pdf
January 01, 2019 - These changes are the
first phase of a set of capabilities meant to build greater trust in the Repository
-
www.ahrq.gov/sites/default/files/publications/files/prioritization-report_0.pdf
January 01, 2020 - Inventory and Prioritization of Measures To Support the Growing Effort in Transparency Using All-Payer Claims Databases
Final Contract Report
Inventory and Prioritization of Measures To
Support the Growing Effort in Transparency
Using All-Payer Claims Databases
Prepared for:
Agency for Healthcare Research and …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-app-g2-3.xlsx
January 01, 2022 - G-2. RoB Assessment
Table G-2. Risk of bias assessment of prior report studies
Author, Year
Selection Bias:
Randomization Adequate? Selection Bias:
Allocation Concealment Adequate? Selection Bias:
Groups Similar at Baseline?
Selection Bias:
ITT Analysis? Performance Bias:
Care Providers Masked? Performance Bias:
Pa…
-
digital.ahrq.gov/sites/default/files/docs/quality-metrics-transcript-042811.pdf
December 31, 2007 - been live on the electronic health records system and the three
previous sites were in the early phase
-
effectivehealthcare.ahrq.gov/sites/default/files/technical-brief-36-patient-engagement-comments.pdf
August 26, 2020 - interventions that use time series
analyses or simple pre- and post-
analyses where the pre-intervention phase
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_disposition-comments.pdf
January 27, 2014 - human
allogeneic fibroblasts and keratinocytes for the treatment of
chronic venous leg ulcers: a phase
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-113-fullreport.pdf
May 01, 2018 - During our feasibility assessment phase, we asked institutions whether the payment source was
available
-
cdsic.ahrq.gov/sites/default/files/2024-07/SRF_Taxonomy%20of%20PC%20CDS%20Override%20Recommendations_508_0.pdf
January 01, 2024 - CDS Standards and Regulatory Frameworks Workgroup: An Initial Taxonomy of Override Reasons for PC CDS Recommendations
CDS Standards and
Regulatory Frameworks
Workgroup:
An Initial Taxonomy of
Override Reasons for PC
CDS Recommendations
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville…
-
effectivehealthcare.ahrq.gov/sites/default/files/mcda_webinar_transcript2.pdf
August 27, 2012 - Integrating Stakeholder Preferences in Comparative Effectiveness Research: Potential Uses of Multi-Criteria Decision Analysis Techniques
AHRQ’s Community Forum
CENTER FOR MEDICAL TECHNOLOGY POLICY
Integrating Stakeholder Preferences in Comparative
Effectiveness Research: Potential Uses of Multi-Criteria De…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_executive.pdf
January 01, 2010 - 1
Comparative Effectiveness Review
Number 102
Screening for Methicillin-Resistant
Staphylococcus Aureus (MRSA)
Executive Summary
Background
Methicillin-resistant Staphylococcus
aureus (MRSA) emerged as a clinically
relevant human pathogen more than
five decades ago.1 The virulent bacterium
was first detecte…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
March 01, 2012 - The 1994 Guidance Document also affirmed the use of
DXA and bone turnover markers for phase I and II